Ultrasound-Enhancing Agents Market Outlook 2031
The ultrasound-enhancing agents market forecast is derived on the basis of findings from various secondary and primary research sources. According to The Insight Partners' estimates, the market was valued at US$ 756.61 million in 2023 and is expected to reach US$ 2,511.52 million by 2031; it is estimated to record a CAGR of 16.2% during 2023–2031.
Ultrasound-enhancing agents, also known as ultrasound contrast agents (UCA), are injected to enhance the resolution of images of the organs during an ultrasound scan. These agents consist of suspensions of gas-filled microbubbles smaller than red blood cells and reflect ultrasound signals as they flow through the microcirculation in the blood vessels. They are expelled from the body via urine or bowel movements, within minutes after injection. These agents do not contain any dyes and are considered safe as they pose no known risk of nephrotoxicity.
Factors Driving Ultrasound-Enhancing Agents Market Growth
Ultrasound imaging is currently the first step in estimating the severity of oncological diseases and cardiovascular conditions, paving the way for accurate assessment and diagnosis through further investigation. It is widely used for real-time imaging of body parts for the detection of abnormalities due to the portability, low cost, safety, and diagnostic capabilities of the system. In addition, using contrast agents has significantly improved the sensitivity and specificity of ultrasound for detecting earlier stages of diseases, thus opening up new possibilities for cellular and molecular research in this field. The surging prevalence of chronic diseases such as cancer, kidney diseases, and liver disorders propels the demand for early diagnoses for better management. Their diagnoses necessitate advanced imaging modalities for early detection and health monitoring among diagnosed patients. Ultrasound-enhancing agents enable enhanced visualization of tumors, lesions, and abnormal tissue growth. According to an article published in radiopaedia.org in September 2023, Sonazoid, a contrast agent used in ultrasound imaging, enhances the liver's contrast in the postvascular phase, which can help detect liver tumors, especially those without Kupffer cell metastases. Sonazoid also helps differentiate between regenerative and dysplastic nodules from early-phase hepatocellular carcinomas in a cirrhotic liver. Therefore, the rising adoption of UCAs in diagnostic imaging boosts the ultrasound-enhancing agents market size.
According to an article published in October 2021 by the International Contrast Ultrasound Society (ICUS), 57 original research studies focused solely on pediatric patients, including 4,518 children who underwent 4,906 intravenous contrast-enhanced ultrasound examinations as of August 2021. Additionally, comprehensive protocols developed to evaluate clinical safety demonstrated the highly favorable safety profile of UCAs when used intravenously, intravesically, and through other intracavitary procedures.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Ultrasound-Enhancing Agents Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Ultrasound-Enhancing Agents Market: Strategic Insights
![ultrasound-enhancing-agents-market](https://www.theinsightpartners.com/assets/rdimages/ultrasound-enhancing-agents-market-img1.png)
![Analyst Image](https://www.theinsightpartners.com/assets/mrinal_kerhalkar.jpg)
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
![Analyst Image](https://www.theinsightpartners.com/assets/images/speak_analyst.gif)
Report Segmentation and Scope:
The "Global Ultrasound-Enhancing Agents Market Analysis to 2031" is a specialized and in-depth study focusing on the global market dynamics to help identify the key driving factors, future trends, and lucrative opportunities that would, in turn, aid in identifying major revenue pockets. The report aims to provide an overview of the market with detailed market segmentation by type, application, and end user. The geographic scope of the ultrasound-enhancing agents market report entails North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Segmental Analysis:
The ultrasound-enhancing agents market, by type, is bifurcated into the first generation and second generation. The second generation segment held a larger market share in 2023. It is projected to register a higher CAGR from 2023 to 2031.
The market, by application, is segmented into abdominal imaging, cardiovascular imaging, urinary tract imaging, and others. The abdominal imaging segment accounted for the largest ultrasound-enhancing agents market share in 2023. The cardiovascular imaging segment is projected to register the highest CAGR from 2023 to 2031.
Based on end user, the market is segmented into hospitals, diagnostic and imaging centers, and others. The hospitals segment held the largest share of the market in 2023. Further, the diagnostic and imaging centers segment is expected to register the highest CAGR from 2023 to 2031.
Regional Outlook:
North America held the largest ultrasound-enhancing agents market share in 2023. The US dominated the market in this region, in terms of share, followed by Canada. Market growth in the US is attributed to factors such as the presence of major players, including Lantheus Holdings Inc. and GE Healthcare. These companies are increasingly focusing on joint ventures and research collaborations. For instance, GE Healthcare focuses on expanding its product portfolio by launching innovative products and entering strategic partnerships with competitors. In addition, an upsurge in the number of ultrasound procedures due to favorable reimbursement policies supports the ultrasound-enhancing agents market growth in the US.
Industry Developments and Future Opportunities:
As per company press releases, a few initiatives taken by key players operating in the global ultrasound-enhancing agents market are listed below:
- In March 2024, Samsung Medison and Bracco Imaging endorsed a Memorandum of Understanding (MoU) agreement to develop a new area for diagnostic ultrasound devices and contrast agents at the European Congress of Radiology (ECR) 2024, held between February 28 to March 3 in Vienna, Austria. Two companies are considering collaborating to develop high-frequency and super-resolution imaging protocols for diagnosis. The collaboration would also include marketing activities, healthcare providers’ education, and exploration of ultrasound-targeted contrast-enhanced drug delivery technologies with pharmaceutical agents.
- In April 2023, GE HealthCare launched Pixxoscan (Gadobutrol). It is a macrocyclic, gadolinium-based contrast agent (GBCA) for nonionic magnetic resonance imaging. The product was added to the company’s MRI contrast media portfolio, which includes Claiscan (macrocyclic gadoteric acid) and Rapiscan (used in stress cardiac MR to aid diagnosis of coronary artery disease).
Ultrasound-Enhancing Agents Market Report Scope
Competitive Landscape and Key Companies:
Lantheus Holdings Inc.; GE Healthcare; Solstice Pharmaceuticals B.V.; FUJIFILM VisualSonics, Inc.; Bracco Diagnostics Inc.; Bayer AG; and Vesselon are among the prominent companies profiled in the ultrasound-enhancing agents market report. These companies focus on new technologies, existing product advancements, and geographic expansions to meet the growing consumer demand worldwide.
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The ultrasound-enhancing agents market majorly consists of the players, including Lantheus Holdings Inc.; GE Healthcare; Solstice Pharmaceuticals B.V.; FUJIFILM VisualSonics, Inc.; Bracco Diagnostics Inc.; Bayer AG; and Vesselon.
The ultrasound-enhancing agents market is expected to be valued at US$ 2,511.52 million in 2031.
The ultrasound-enhancing agents market is bifurcated into the first generation and second generation. The second generation segment held a larger market share in 2023. It is projected to register a higher CAGR from 2023 to 2031.
Ultrasound-enhancing agents, also known as ultrasound contrast agents (UCA), are injected to enhance the resolution of images of the organs during an ultrasound scan. These agents consist of suspensions of gas-filled microbubbles smaller than red blood cells and reflect ultrasound signals as they flow through the microcirculation in the blood vessels. They are expelled from the body via urine or bowel movements, within minutes after injection. These agents do not contain any dyes and are considered safe as they pose no known risk of nephrotoxicity.
The ultrasound-enhancing agents informatics was valued at US$ 756.61 million in 2023.
Key factors driving the ultrasound-enhancing agents informatics growth are the increasing investments in the R&D of new drug molecules by pharmaceutical companies and the growing adoption of computational and information tools for ultrasound-enhancing agents and development.
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Ultrasound-Enhancing Agents Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Ultrasound-Enhancing Agents Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Ultrasound-Enhancing Agents Market - Global Market Analysis
6.1 Ultrasound-Enhancing Agents - Global Market Overview
6.2 Ultrasound-Enhancing Agents - Global Market and Forecast to 2031
7. Ultrasound-Enhancing Agents Market – Revenue Analysis (USD Million) – By Type, 2021-2031
7.1 Overview
7.2 First Generation
7.3 Second Generation
8. Ultrasound-Enhancing Agents Market – Revenue Analysis (USD Million) – By Application, 2021-2031
8.1 Overview
8.2 Abdominal Imaging
8.3 Cardiovascular Imaging
8.4 Urinary Tract Imaging
8.5 Others
9. Ultrasound-Enhancing Agents Market – Revenue Analysis (USD Million) – By End User, 2021-2031
9.1 Overview
9.2 Hospitals
9.3 Diagnostic and Imaging Centers
9.4 Others
10. Ultrasound-Enhancing Agents Market - Revenue Analysis (USD Million), 2021-2031 – Geographical Analysis
10.1 North America
10.1.1 North America Ultrasound-Enhancing Agents Market Overview
10.1.2 North America Ultrasound-Enhancing Agents Market Revenue and Forecasts to 2031
10.1.3 North America Ultrasound-Enhancing Agents Market Revenue and Forecasts and Analysis - By Type
10.1.4 North America Ultrasound-Enhancing Agents Market Revenue and Forecasts and Analysis - By Application
10.1.5 North America Ultrasound-Enhancing Agents Market Revenue and Forecasts and Analysis - By End User
10.1.6 North America Ultrasound-Enhancing Agents Market Revenue and Forecasts and Analysis - By Countries
10.1.6.1 United States Ultrasound-Enhancing Agents Market
10.1.6.1.1 United States Ultrasound-Enhancing Agents Market, by Type
10.1.6.1.2 United States Ultrasound-Enhancing Agents Market, by Application
10.1.6.1.3 United States Ultrasound-Enhancing Agents Market, by End User
10.1.6.2 Canada Ultrasound-Enhancing Agents Market
10.1.6.2.1 Canada Ultrasound-Enhancing Agents Market, by Type
10.1.6.2.2 Canada Ultrasound-Enhancing Agents Market, by Application
10.1.6.2.3 Canada Ultrasound-Enhancing Agents Market, by End User
10.1.6.3 Mexico Ultrasound-Enhancing Agents Market
10.1.6.3.1 Mexico Ultrasound-Enhancing Agents Market, by Type
10.1.6.3.2 Mexico Ultrasound-Enhancing Agents Market, by Application
10.1.6.3.3 Mexico Ultrasound-Enhancing Agents Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
10.4.1 South Africa
10.4.2 Saudi Arabia
10.4.3 U.A.E
10.4.4 Rest of Middle East and Africa
10.5 South and Central America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Rest of South and Central America
11. Industry Landscape
11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration
13. Ultrasound-Enhancing Agents Market - Key Company Profiles
13.1 Lantheus Holdings Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
Note - Similar information would be provided for below list of companies
13.2 GE Healthcare
13.3 Solstice Pharmaceuticals B.V.
13.4 FUJIFILM VisualSonics, Inc
13.5 Bracco Diagnostics Inc
13.6 Bayer AG
13.7 Vesselon
14. Appendix
14.1 Glossary
14.2 About The Insight Partners
14.3 Market Intelligence Cloud
The List of Companies - Ultrasound-Enhancing Agents Market
- Lantheus Holdings Inc.
- GE Healthcare
- Solstice Pharmaceuticals BV
- FUJIFILM VisualSonics, Inc.
- Bracco Diagnostics Inc.
- Bayer AG
- Vesselon
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Ultrasound-Enhancing Agents Market
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
May 2024
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
May 2024
Smart Hospital Beds Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Patient Weight (Less than 70 lb, 70 to 150 lb, 150 to 400 lb, 400 to 500 lb, Greater than 500 lb); Offering (Products and Accessories, Software and Solutions, and Services); Application (Fall Prevention, Pressure Injury Prevention, Patient Deterioration and Monitoring, and Others); End User (Hospitals, Clinics and Nursing Homes, Ambulatory Surgical Centers, Medical Laboratories, Long Term Care Centers, and Others), and Geography
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
May 2024
Heart Transplant Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Surgery Type (Orthotopic Heart Transplant and Heterotopic Heart Transplant), Type (Donor Live Heart and Artificial Hearts), End User (Hospitals, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
May 2024
Breath Analyzer Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Fuel Cell Technology, Semiconductor Sensor, Infrared Spectroscopy, and Others), Application (Drug Abuse Detection, Alcohol Detection, and Medical Applications), End User (Law Enforcement Agencies, Hospitals & Diagnostic Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
May 2024
Osteoarthritis Therapy Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type (TENS, Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others), Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals and Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
May 2024
Surgical Navigation Systems Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Optical Navigation System, Electromagnetic Navigation System, Hybrid Navigation System, Fluoroscopy Navigation System, CT-Based Navigation System, and Others), Application (Orthopedic, ENT, Neurology, Dental, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
May 2024
Skull Clamp Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Three-Pin Skull Clamp, Four-Pin Skull Clamp, and Two-Pin Skull Clamp), Application (Surgery and Medical Imaging), Material (Stainless Steel, Aluminum Alloy, Titanium, and Radiolucent), Accessories (Skull Pins, Headrest, and Others), End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
![Cover Image](https://www.theinsightpartners.com/assets/images/other/tip-sample-cover.jpg)
May 2024
Teleradiology Services Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Deployment Type (Cloud-based, Web-based), Modality (MRI, CT-Scan, X-ray, Ultrasound, Others), Application (Musculoskeletal System, Gastroentrology, Cardiology, Oncology, Neurology, Others), End User (Hospitals and Clinics, Diagnostic and Imaging Centers, Others), and Geography